Also trades as: ABBOTINDIA.NS (NSE) · $vol 3M

₹26,780.00 ($278.09)

-369.40 (-1.36%)

BSE · Healthcare · Drug Manufacturers - General · Tech Score Buy · Power 61 · ₹569.6B mcap · 5M float · 0.012% daily turnover

Revenue

$69.3B +8.1% ▲

5Y CAGR: +10.0%

Gross Profit

$25.1B -13.3% ▼

5Y CAGR: +5.6%

Operating Income

$18.3B +11.5% ▲

5Y CAGR: +16.0%

Net Income

$15.5B +9.7% ▲

5Y CAGR: +17.6%

EPS (Diluted)

$730.37 +9.7% ▲

5Y CAGR: +17.6%

EBITDA

$21.7B +10.3% ▲

5Y CAGR: +16.8%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$49.1B	$53.5B	$58.5B	$64.1B	$69.3B
YoY Growth	+14.0%	+8.9%	+9.4%	+9.6%	+8.1%
Cost of Revenue	$26.7B	$29.9B	$32.3B	$35.0B	$44.2B
Gross Profit	$22.4B	$23.6B	$26.1B	$29.1B	$25.1B
Gross Margin	45.7%	44.2%	44.7%	45.4%	36.2%
R&D Expenses	$8M	$8M	$10M	$10M	$0
SG&A Expenses	$4.1B	$3.5B	$3.4B	$6.9B	$3.2B
Operating Expenses	$12.2B	$12.2B	$12.1B	$12.9B	$6.8B
Operating Income	$10.3B	$11.5B	$14.1B	$16.2B	$18.3B
Operating Margin	20.9%	21.5%	24.0%	25.3%	26.5%
Interest Expense	$191M	$160M	$124M	$114M	$188M
Income Before Tax	$10.8B	$12.7B	$16.2B	$18.9B	$20.8B
Tax Expense	$2.8B	$3.2B	$4.2B	$4.7B	$5.3B
Net Income	$8.0B	$9.5B	$12.0B	$14.1B	$15.5B
Net Margin	16.3%	17.8%	20.5%	22.1%	22.4%
EPS (Diluted)	$375.87	$446.80	$565.30	$665.62	$730.37
EBITDA	$11.6B	$13.6B	$17.0B	$19.7B	$21.7B
Shares Outstanding	21M	21M	21M	21M	21M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$15.6B	$16.3B	$16.1B	$16.0B	$17.4B	$17.6B	$17.2B	$17.1B
Cost of Revenue	$8.5B	$9.0B	$8.9B	$8.7B	$9.4B	$9.4B	$9.1B	$10.7B
Gross Profit	$7.1B	$7.3B	$7.2B	$7.3B	$8.0B	$8.2B	$8.2B	$6.4B
Gross Margin	45.7%	44.8%	44.7%	45.7%	45.8%	46.7%	47.3%	37.4%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$0	$1.4B	$1.3B	$2.5B	$1.7B	$0	$1.6B	$1.8B
Operating Expenses	$3.4B	$3.1B	$3.0B	$3.0B	$3.7B	$3.4B	$3.7B	$1.8B
Operating Income	$3.7B	$4.2B	$4.2B	$4.3B	$4.3B	$4.8B	$4.4B	$4.6B
Operating Margin	23.9%	25.8%	25.9%	27.0%	24.5%	27.5%	25.8%	27.0%
Interest Expense	$28M	$25M	$23M	$39M	$58M	$76M	$55M	$61M
Income Before Tax	$4.4B	$4.8B	$4.9B	$4.8B	$4.9B	$5.5B	$5.1B	$5.3B
Tax Expense	$1.1B	$1.2B	$1.3B	$1.2B	$1.3B	$1.3B	$1.3B	$1.4B
Net Income	$3.3B	$3.6B	$3.6B	$3.7B	$3.7B	$4.2B	$3.8B	$3.9B
Net Margin	21.1%	22.0%	22.3%	22.9%	21.0%	23.6%	21.8%	23.1%
EPS (Diluted)	$154.36	$168.76	$169.78	$172.72	$172.17	$195.42	$176.93	$185.85
EBITDA	$4.6B	$5.0B	$5.1B	$5.0B	$5.2B	$5.7B	$5.3B	$5.6B
Shares Outstanding	21M	21M	21M	21M	21M	21M	21M	21M

ABBOTINDIA.BO BSE